Literature DB >> 1901349

Recombinant tissue plasminogen activator in two patients with basilar artery occlusion.

D Herderscheê1, M Limburg, A Hijdra, P A Koster.   

Abstract

Two patients with angiographically proved basilar artery occlusion were treated with systemic recombinant tissue plasminogen activator (rtPA) according to protocol. The first patient was in a locked-in state and gradually deteriorated. On repeat angiography the basilar artery remained occluded. He died and necropsy revealed a pontine haemorrhagic infarction. The second patient, who was comatose and with decerebrate posturing, made a remarkable recovery. Angiography showed reperfusion. Therapy was initiated in the first patient after six hours and in the second after two hours. Treatment with rtPA is promising but probably not feasible for every patient. Success may depend on duration of occlusion and composition of occluding thrombus.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1901349      PMCID: PMC1014304          DOI: 10.1136/jnnp.54.1.71

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  11 in total

1.  Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease.

Authors:  W Hacke; H Zeumer; A Ferbert; H Brückmann; G J del Zoppo
Journal:  Stroke       Date:  1988-10       Impact factor: 7.914

2.  'Convulsions' in basilar artery occlusion.

Authors:  A H Ropper
Journal:  Neurology       Date:  1988-09       Impact factor: 9.910

Review 3.  Thrombolytic therapy: current status (1).

Authors:  V J Marder; S Sherry
Journal:  N Engl J Med       Date:  1988-06-09       Impact factor: 91.245

4.  Lysis of basilar artery occlusion with tissue plasminogen activator.

Authors:  T Henze; A Boeer; U Tebbe; J Romatowski
Journal:  Lancet       Date:  1987-12-12       Impact factor: 79.321

5.  Basilar artery occlusion: clinical and radiological correlation.

Authors:  C R Archer; S Horenstein
Journal:  Stroke       Date:  1977 May-Jun       Impact factor: 7.914

6.  Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator.

Authors:  K L Neuhaus; W Feuerer; S Jeep-Tebbe; W Niederer; A Vogt; U Tebbe
Journal:  J Am Coll Cardiol       Date:  1989-11-15       Impact factor: 24.094

7.  Locked-in syndrome: a review of 139 cases.

Authors:  J R Patterson; M Grabois
Journal:  Stroke       Date:  1986 Jul-Aug       Impact factor: 7.914

8.  Artery-to-artery embolism causing stroke in the posterior circulation.

Authors:  W J Koroshetz; A H Ropper
Journal:  Neurology       Date:  1987-02       Impact factor: 9.910

9.  Intraluminal clot in the vertebrobasilar circulation: clinical and radiologic features.

Authors:  S R Levine; D J Quint; M S Pessin; R S Boulos; K M Welch
Journal:  Neurology       Date:  1989-04       Impact factor: 9.910

10.  Clinical features and mechanism of occipital infarction.

Authors:  M S Pessin; E S Lathi; M B Cohen; E S Kwan; T R Hedges; L R Caplan
Journal:  Ann Neurol       Date:  1987-03       Impact factor: 10.422

View more
  4 in total

Review 1.  Basilar artery occlusion.

Authors:  Tracey A Baird; Keith W Muir; Ian Bone
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

Review 2.  Thrombolytic therapy. From myocardial to cerebral infarction. The MAST-I Group. Multicentre Acute Stroke Trial.

Authors:  L Candelise; C Roncaglioni; E Aritzu; A Ciccone; A P Maggioni
Journal:  Ital J Neurol Sci       Date:  1996-02

3.  Heralding manifestations of basilar artery occlusion with lethal or severe stroke.

Authors:  G von Campe; F Regli; J Bogousslavsky
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-12       Impact factor: 10.154

4.  'Bats below the bridge': is a potentially treatable neurovascular disorder being underdiagnosed in accident and emergency departments?

Authors:  D Hulbert; S Gabe; D Potts; J A Ball; R Touquet
Journal:  J Accid Emerg Med       Date:  1994-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.